Andrea S. Blevins Primeau, PhD, MBA

Andrea S. Blevins Primeau, PhD, MBA, is a freelance medical writer and editor based in central Pennsylvania. She enjoys writing about a variety of topics including oncology, cardiovascular disease, and autoimmune disorders. Previously, she conducted research investigating the role of pharmacogenetics on the efficacy of oncologic therapies.

Most Recent Articles by Andrea S. Blevins Primeau, PhD, MBA

Managing Immune-Related Adverse Events

Managing Immune-Related Adverse Events

By

An overview of the potential immune-related adverse events that can arise from treatment with checkpoint inhibitors.

Managing Neutropenia

Managing Neutropenia

By

Both the chemotherapy regimen selected and therapeutic dose intensity used in treatment factor into the calculation of neutropenia risk.

Genetic Testing and Cancer

Genetic Testing and Cancer

By

Traditional genetic testing historically included the sequential analysis of single and generally well-described genes involved in heritable cancers.

Psychotherapy and Cancer

Psychotherapy and Cancer

By

Some data suggest that psychotherapy may benefit patients with cancer, but higher-quality research is needed.

Polypharmacy and Cancer

Polypharmacy and Cancer

By

The effect of polypharmacy and noncancer mortality on patient survival and other outcomes in cancer varies by study.

More Articles by Andrea S. Blevins Primeau, PhD, MBA

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs